Catalyst

Slingshot members are tracking this event:

Lexicon Pharma (LXRX) Presents Data from Phase 3 Tandem2 Trial Evaluating Orally Administered Sotagliflozin in Adult Type 1 Diabetics

Source Link:
http://www.lexpharma.com/media-center/news/617-lexicon-reports-positive-top-line-results-in-second-pivotal-phase-3-study-for-sotagliflozin-in-patients-with-type-1-diabetes

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
LXRX
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Dec 21, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3, Tandem2, Orally Administered, Sotagliflozin, Type 1 Diabetes, Adults
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.